Pancreatic Cancer Research

ResearcherShenzhen UniversityActive in the last 2 years

Hui Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4867-7788; OpenAlex author ID A5100387583. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. Doxorubicin-NFL-TBS.40-63 peptide Gold Complex Nanovector (DOX IN-NFL@AuNPs): Efficacy Evaluation in a mouse transplantation tumor model induced by PANC-1/ADR … Co-author DOI 10.7150/ntno.109280↗
  2. CD105+CAF-derived exosomes CircAMPK1 promotes pancreatic cancer progression by activating autophagy. Last author DOI 10.1186/s40164-024-00533-3↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaowu Li · 2 shared papers, 2024–2025 · strength 0.56
  2. Qiqian Liu · 1 shared paper, 2025 · strength 0.30
  3. Jolanda Spadavecchia · 1 shared paper, 2025 · strength 0.30
  4. Shiyu Chen · 1 shared paper, 2024 · strength 0.26
  5. Kun Cai · 1 shared paper, 2024 · strength 0.26
  6. Zhiwei He · 1 shared paper, 2024 · strength 0.26
  7. Xiushen Li · 1 shared paper, 2024 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.